I look forward to a robust discussion today. I am looking forward to starting the appropriations process and working with all the members of this subcommittee to draft an Agriculture Bill that supports these vital programs.
Martin Heinrich
The Public Record
Martin Heinrich is a United States Senator from New Mexico, serving since January 3, 2013. A member of the Democratic Party, Heinrich previously represented New Mexico's 1st congressional district in the U.S. House of Representatives from January 6, 2009, to January 3, 2013. Throughout his political career, he has focused on issues such as renewable energy, healthcare, and economic development, advocating for policies that benefit New Mexico's diverse communities.
I think we ought to do our level best not only to hold them accountable to make sure they are following the Packers and Stockyards Act, but hold them to extremely high standards, when it comes to bringing in Brazilian beef.
Unless we decouple, unless we figure out ways in which we can encourage reinvestment back in these facilities, and continue to provide housing that is affordable for folks, we are going to have a serious problem in communities.
More than 500 family in New Mexico alone, and 65,000 families across the Nation, could lose access to affordable housing over the next 10 years.
I think it is important for people to realize that these are not one-time emergencies.
The programs and activities of this Department affect every single American, from farmers, and rural communities, to children and families who depend on healthy and nutritious food.
This subcommittee must ensure that USDA has the resources you need to fulfill your broad and absolutely critical mission.
We also know that affordable housing is a major challenge, not just in my home State of New Mexico, but really across the Nation.
I am pleased that the budget focuses on providing tools to producers in rural communities to address the climate crisis.
We should all be concerned because the nature of the epidemic is changing significantly from just the prescription misuse to now cartels driving fentanyl.
This sets an incredibly dangerous precedent in terms of both women's reproductive rights but also the FDA's review of drugs.
The decisions the FDA makes, whether approving a medical device or approving a new drug, must be guided by science and data, not by political pressure.
This judge has replaced his political agenda for the data-driven process used by the FDA.
These changes will help maintain and improve access to safe, affordable housing for low-income Americans.
I think it is important for people to realize that these are not one-time emergencies.
I look forward to a robust discussion today. I am looking forward to starting the appropriations process and working with all the members of this subcommittee to draft an Agriculture Bill that supports these vital programs.
More than 500 family in New Mexico alone, and 65,000 families across the Nation, could lose access to affordable housing over the next 10 years.
We also know that affordable housing is a major challenge, not just in my home State of New Mexico, but really across the Nation.
The programs and activities of this Department affect every single American, from farmers, and rural communities, to children and families who depend on healthy and nutritious food.
The budget request for United States Department of Agriculture (USDA) is ambitious, and it includes significant increases across the board.
Unless we decouple, unless we figure out ways in which we can encourage reinvestment back in these facilities, and continue to provide housing that is affordable for folks, we are going to have a serious problem in communities.
I am pleased that the budget focuses on providing tools to producers in rural communities to address the climate crisis.
This is my first hearing as chairman of this subcommittee, and I am looking forward to a good discussion on the fiscal year 2024 Budget Request for the Department of Agriculture.
This sets an incredibly dangerous precedent in terms of both women's reproductive rights but also the FDA's review of drugs.





